Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency?

References

• Hof H, Herfarth KK, Munter M, Hoess A, Motsch J, Wannenmacher M, et al. Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 2003; 56: 335–41
   PubMed Web of Science ®Google Scholar
• Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005; 63: 1427–31
   PubMed Web of Science ®Google Scholar
• Timmerman R, Papiez L, McGarry R, Likes L, DesRosiers C, Frost S, et al. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003; 124: 1946–55
   PubMed Web of Science ®Google Scholar
• Nyman J, Johansson KA, Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer–mature results for medically inoperable patients. Lung Cancer 2006; 51: 97–103
   PubMed Web of Science ®Google Scholar
• Kwa SL, Lebesque JV, Theuws JC, Marks LB, Munley MT, Bentel G, et al. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 1998; 42: 1–9
   PubMed Web of Science ®Google Scholar
• Rodrigues G, Lock M, D'Souza D, Yu E, Van Dyk J. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer–a systematic review. Radiother Oncol 2004; 71: 127–38
   PubMed Web of Science ®Google Scholar
• Clenton SJ, Fisher PM, Conway J, Kirkbride P, Hatton MQ. The use of lung dose-volume histograms in predicting post-radiation pneumonitis after non-conventionally fractionated radiotherapy for thoracic carcinoma. Clin Oncol (R Coll Radiol) 2005; 17: 599–603
   PubMedGoogle Scholar
• Hoyer M, Roed H, Sengelov L, Traberg A, Ohlhuis L, Pedersen J, et al. Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother Oncol 2005; 76: 48–53
   PubMed Web of Science ®Google Scholar
• Hoyer M, Roed H, Traberg HA, Ohlhuis L, Petersen J, Nelleman H, et al. Prospective study on stereotactic radiotherapy of limited stage non-small cell lung cancer. 2006; ( in press).
   Google Scholar
• Hiraoka M, Nagata Y. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: The Japanese experience. Int J Clin Oncol 2004; 9: 352–5
   PubMedGoogle Scholar
• Onishi H, Araki T, Shirato H, Nagata Y, Hiraoka M, Gomi K, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004; 101: 1623–31
   PubMed Web of Science ®Google Scholar
• Zimmermann FB, Geinitz H, Schill S, Grosu A, Schratzenstaller U, Molls M, et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 2005; 48: 107–14
   PubMed Web of Science ®Google Scholar
• Ohashi T, Takeda A, Shigematsu N, Kunieda E, Ishizaka A, Fukada J, et al. Differences in pulmonary function before vs. 1 year after hypofractionated stereotactic radiotherapy for small peripheral lung tumors. Int J Radiat Oncol Biol Phys 2005; 62: 1003–8
   PubMedGoogle Scholar
• Wulf J, Hadinger U, Oppitz U, Thiele W, Ness-Dourdoumas R, Flentje M. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 2001; 177: 645–55
   PubMed Web of Science ®Google Scholar
• Nagata Y, Negoro Y, Aoki T, Mizowaki T, Takayama K, Kokubo M, et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2002; 52: 1041–6
   PubMed Web of Science ®Google Scholar
• Uematsu M, Shioda A, Suda A, Fukui T, Ozeki Y, Hama Y, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: A 5-year experience. Int J Radiat Oncol Biol Phys 2001; 51: 666–70
   PubMed Web of Science ®Google Scholar
• McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 2005; 63: 1010–5
   PubMed Web of Science ®Google Scholar
• Fukumoto S, Shirato H, Shimzu S, Ogura S, Onimaru R, Kitamura K, et al. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas. Cancer 2002; 95: 1546–53
   PubMed Web of Science ®Google Scholar
• Carey SM, Katz A, Constine LS. Stereotactic body radiation therapy for extracranial oligometastases: Does the sword have a double edge?. Semin Radiat Oncol 2006; 16: 67–76
   PubMedGoogle Scholar